OPN is involved in NAFLD pathogenesis (Kiefer et al., 2011), and its liver expression is increased in obesity and correlates with steatosis and insulin resistance (Gómez‐Ambrosi et al., 2007). The gene discussed is SPP1; the disease is metabolic dysfunction-associated steatotic liver disease.